SCHEDULE: RA Capital Management Boosts Stake in Geron Corp to 9.9%

RA Capital Management and its affiliates now beneficially own 9.9% of Geron Corporation's common stock, primarily through RA Capital Healthcare Fund, L.P., following an amendment to their Schedule 13G filing.

Summary

• RA Capital Management, L.P., along with Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P., have filed an amendment to their Schedule 13G, reporting beneficial ownership of 66,502,728 shares of Geron Corporation's common stock.
• This represents 9.9% of the outstanding common stock as of June 30, 2026.
• The filing indicates that RA Capital Healthcare Fund, L.P. directly holds 42,809,751 shares and pre-funded warrants exercisable for up to 29,053,145 shares.
• A 'Beneficial Ownership Blocker' in the pre-funded warrants limits the exercise to prevent ownership exceeding 9.99%, currently capping beneficial ownership at 66,502,728 shares.
• RA Capital Management serves as the investment adviser for the Fund and has been delegated sole voting and dispositive power over the securities held by the Fund.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, indicating significant beneficial ownership by RA Capital Management and its affiliates, which could signal confidence in Geron Corporation's future prospects.

Positives

• Significant beneficial ownership of 9.9% by RA Capital Management and its affiliates suggests a strong conviction in Geron Corporation's value and future prospects.
• The substantial holding by a well-known investment firm like RA Capital can be interpreted as a positive signal to the market.
• The filing details the structure of ownership, including direct shareholdings and exercisable warrants, providing transparency.

Negatives

• The 'Beneficial Ownership Blocker' in the pre-funded warrants restricts the full exercise of these warrants, capping the potential ownership stake at 9.99% and limiting immediate upside from warrant exercise.
• The disclaimer of beneficial ownership by RA Capital, Dr. Kolchinsky, and Mr. Shah for purposes other than Section 13(d) obligations indicates they do not seek control or influence over the issuer.

Risks

• The 'Beneficial Ownership Blocker' poses a risk of not being able to fully exercise warrants if the ownership threshold is approached, potentially limiting returns.
• The reliance on RA Capital Management for voting and dispositive power means that decisions regarding these shares are centralized, which could be a risk if RA Capital's strategy changes.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Geron Corporation. It solely reports on the beneficial ownership of RA Capital Management and its affiliates.

Management Comments

• RA Capital Management, L.P. serves as investment adviser for the Fund and may be deemed a beneficial owner, for purposes of Section 13(d) of the Act, of any securities of the Issuer held by the Fund.
• The Fund has delegated to RA Capital the sole power to vote and the sole power to dispose of all securities held in the Fund's portfolio, including the shares of the Issuer's common stock reported herein.
• Because the Fund has divested voting and investment power over the reported securities it holds and may not revoke that delegation on less than 61 days' notice, the Fund disclaims beneficial ownership of the securities it holds for purposes of Section 13(d) of the Act.
• As managers of RA Capital, Dr. Kolchinsky and Mr. Shah may be deemed beneficial owners, for purposes of Section 13(d) of the Act, of any securities of the Issuer beneficially owned by RA Capital.
• RA Capital, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of the securities reported in this Schedule 13G/A other than for the purpose of determining their obligations under Section 13(d) of the Act, and the filing of this Schedule 13G/A shall not be deemed an admission that either RA Capital, Dr. Kolchinsky, or Mr. Shah is the beneficial owner of such securities for any other purpose.

Industry Context

StockSavvy.ai notes that significant stake-building by institutional investors like RA Capital Management often signals a belief in the company's underlying technology or market potential, particularly in the biotechnology sector where Geron operates. This level of ownership can also lead to increased engagement with management.

Stakeholder Impact

• Shareholders: The increased stake by a significant investor may be viewed positively, potentially influencing share price and signaling confidence.
• Management: May face increased scrutiny or engagement from RA Capital Management regarding corporate strategy and performance.
• Creditors: No direct impact mentioned, but sustained investor confidence can indirectly support the company's financial stability.

Next Steps

• RA Capital Management will continue to manage the beneficial ownership of Geron Corporation's common stock as per its investment strategy.
• Geron Corporation will continue its operations and report its financial and operational results in subsequent filings.

Key Dates

Recommendation

The filing indicates a significant increase in beneficial ownership by RA Capital Management, reaching a 9.9% stake. While this suggests investor confidence, the presence of a beneficial ownership blocker limits immediate upside from warrant exercise and the filing itself does not provide operational or financial performance data for Geron Corporation. Therefore, a 'hold' recommendation is appropriate pending further information on the company's performance.

Keywords

Geron Corporation, RA Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Pre-funded Warrants, Healthcare Fund